Siang-Boon Koh

11PUBLICATIONS
25CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsNuclear medicineCancer therapy (excl. chemotherapy and radiation therapy)Fuzzy computation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 04, 2025
Design, synthesis, molecular modeling, and antiproliferative evaluation of new 2-oxoindolin-3-ylidene thiazole derivatives.

|Jan 31, 2025
CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance.

Ki-Fong Man, Omeed Darweesh, Jinghui Hong

|Feb 21, 2024
Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair.

Yumin Wang, Boya Gao, Luyuan Zhang

|Sep 22, 2021
Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses.

Siang-Boon Koh, Brian N Dontchos, Veerle Bossuyt

|Jun 25, 2021
RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer.

Siang-Boon Koh, Kenneth Ross, Steven J Isakoff

|Jun 13, 2018
The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression.

Yann Wallez, Charles R Dunlop, Timothy Isaac Johnson

Pageof 2

Frequent Collaborators

6 joint publications

Leif W Ellisen

2 joint publications

Charles R Dunlop

2 joint publications

Frances M Richards

2 joint publications

Lee Zou